At European Confab, Big Pharma Discusses Burgeoning Role of qPCR in Product Development

Representatives from Novartis Molecular Diagnostics and Sanofi Pasteur weighed in on the increasing use of quantitative PCR in areas such as companion diagnostic development and vaccine analytical testing at an industry meeting this week.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.